Galactosylceramidase, GBA1 and GBA2 activities were increased up to 3-fold in the spinal cord of ALS patients, when ceramide and GSLs were increased, albeit ceramides appear to be preferentially increased in muscle [65,67]. This evidence concerns the gene GBA2 and amyotrophic lateral sclerosis.